Logo image
Development of a novel DNA oligonucleotide targeting low-density lipoprotein receptor
Journal article   Open access   Peer reviewed

Development of a novel DNA oligonucleotide targeting low-density lipoprotein receptor

T. Wang, K. Rahimizadeh and R.N. Veedu
Molecular Therapy - Nucleic Acids, Vol.19, pp.190-198
2019
pdf
Lipoprotein Receptor.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Low-density lipoprotein receptor (LDL-R) is a cell surface receptor protein expressed in a variety of solid cancers including lung, colon, breast, brain and liver, therefore opens up opportunities to deliver lysosome sensitive anti-cancer agents, especially synthetic nucleic acid-based therapeutic mole- cules. In this study, we focused on developing novel nucleic acid molecules specific to LDL-R. For this purpose, we performed in vitro selection procedure via SELEX methodologies using mammalian cell- expressed human recombinant LDL-R protein as a target. After ten rounds of selections, we identified a novel DNA oligonucleotide aptamer, RNV-L7, that can bind specifically to LDL-R protein with high affinity and specificity (Kd = 19.6 nM). Furthermore, flow cytometry and fluorescence imaging assays demonstrated efficient binding to LDL-R over-expressed human cancer cells including Huh-7 liver can- cer cells and MDA-MB-231 breast cancer cells with a binding affinity of ∼200 nM. Furthermore, we evaluated the functional potential of the developed LDL-R aptamer RNV-L7 by conjugating with a pre- viously reported miR-21 targeting DNAzyme for inhibiting miR-21 expression. The results showed that the miR-21 DNAzyme-RNV-L7 aptamer chimera efficiently reduced the expression of miR-21 in Huh- 7 liver cancer cells. As currently there are no reports on LDL-R aptamer development, we believe that RNV-L7 could be beneficial towards the development of targeted cancer therapeutics.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Metrics

27 File views/ downloads
33 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
2 Chemistry
2.145 Biosensors
2.145.243 Nanobiosensors
Web Of Science research areas
Medicine, Research & Experimental
ESI research areas
Biology & Biochemistry
Logo image